| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/25/2010 | WO2010022225A1 Dock-and-lock (dnl) vaccines for cancer therapy |
| 02/25/2010 | WO2010022135A1 Immunological composition |
| 02/25/2010 | WO2010022017A2 Method and composition for enhancing hematopoietic stem cell mobilization |
| 02/25/2010 | WO2010021940A1 Insect proteins as adjuvants to accelerate the immune response |
| 02/25/2010 | WO2010021874A2 Engineered anti-il-13 antibodies, compositions, methods and uses |
| 02/25/2010 | WO2010021729A2 Human notch3 based fusion proteins as decoy inhibitors of notch3 signaling |
| 02/25/2010 | WO2010021516A2 Novel use of lipocalin 2 for treating brain damage |
| 02/25/2010 | WO2010021289A1 Avian influenza virus antigen, and booster immunization method for avian influenza vaccine in combination with mucosal adjuvant which is effective through oral administration |
| 02/25/2010 | WO2010021112A1 Hig2 and urlc10 epitope peptide and vaccines containing the same |
| 02/25/2010 | WO2010021111A1 Inhbb epitope peptides and vaccines containing the same |
| 02/25/2010 | WO2010020694A1 Polynucleotides which down-regulate the expression of the sbi protein |
| 02/25/2010 | WO2010020669A1 Antibodies directed against pyroglutamate monocyte chemoattractant protein-1 (mcp-1 n1pe) |
| 02/25/2010 | WO2010020609A1 Amino alcohol derivatives for the treatment of demyelinating peripheral neuropathies |
| 02/25/2010 | WO2010020593A1 Treatment of an autoimmune disease using il-18 antagonists |
| 02/25/2010 | WO2010020057A1 Treatment and/or Prevention of Peanut Induced Anaphylaxis |
| 02/25/2010 | WO2010020028A1 Synthetic peptides and polymer for leishmaniasis immunization |
| 02/25/2010 | WO2009151697A3 Compositions and processes relating to human bocavirus |
| 02/25/2010 | WO2009143816A4 Method for isolating cells and disease vectors from bodily fluids |
| 02/25/2010 | WO2009142988A3 Chitin micro-particles as an adjuvant |
| 02/25/2010 | WO2009140236A3 Staphylococcus aureus-specific antibody preparations |
| 02/25/2010 | WO2009137632A3 Hiv immunogen and method of making and using same |
| 02/25/2010 | WO2009135181A3 Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation |
| 02/25/2010 | WO2009135118A3 Lyme disease vaccine |
| 02/25/2010 | WO2009128952A3 Compositions of toll-like receptor agonists and papillomavirus antigens and uses thereof |
| 02/25/2010 | WO2009126308A3 Compositions and methods for vaccine and virus production |
| 02/25/2010 | WO2009118660A3 Adam-15 antibodies and immunogenic peptides |
| 02/25/2010 | WO2009114702A3 Recombinant production of authentic human proteins using human cell expression systems |
| 02/25/2010 | WO2009104092A3 Escherichia coli immunogens with improved solubility |
| 02/25/2010 | WO2009101479A3 Fc receptor-binding polypeptides with modified effector functions |
| 02/25/2010 | WO2009013621A3 Antibodies and sirna against growth hormone, prolactin and proliferin for use in the treatment of tumors and endometriosis |
| 02/25/2010 | WO2008142694A3 Peptides and methods for the treatment of systemic lupus erythematosus |
| 02/25/2010 | WO2008094525A3 Detection of influenza virus |
| 02/25/2010 | US20100049491 Method and System for Optimizing Minigenes and Peptides Encoded Thereby |
| 02/25/2010 | US20100048879 Multimerised hiv fusion inhibitors |
| 02/25/2010 | US20100048683 Modified vaccinia virus ankara for the vaccination of neonates |
| 02/25/2010 | US20100048485 Substrates of n-end rule ubiquitylation and methods for measuring the ubiquitylation of these substrate |
| 02/25/2010 | US20100047871 Fusion proteins of hiv regulatory/accessory proteins |
| 02/25/2010 | US20100047818 Diagnosis of carcinomas |
| 02/25/2010 | US20100047809 Pca3, pca3 genes, and methods of use |
| 02/25/2010 | US20100047764 Novel surface protein (HBsAg) variant of the hepatitis B virus |
| 02/25/2010 | US20100047333 Modified Peptides and Their Use for the Treatment of Autoimmune Diseases |
| 02/25/2010 | US20100047331 Method of inducing neutralizing antibodies to human immunodeficiency virus |
| 02/25/2010 | US20100047329 Novel Vaccination Carrier |
| 02/25/2010 | US20100047327 Adjuvant for Transdermal or Transmucosal Administration and Pharmaceutical Preparation Containing the Same |
| 02/25/2010 | US20100047314 Folinic acid derivatives for promoting bone growth |
| 02/25/2010 | US20100047288 Hybrid cells for treating cancer patients |
| 02/25/2010 | US20100047287 Outer membrane vesicles and uses thereof |
| 02/25/2010 | US20100047286 Recombinant BCG strains with enhanced ability to escape the endosome |
| 02/25/2010 | US20100047285 Anticancer agents using verotoxin variants |
| 02/25/2010 | US20100047284 Method for reducing spasms comprising treatment with an agent that elevates the level of one or more cyclic nucleotides in the muscle |
| 02/25/2010 | US20100047283 Francisella strain for live vaccine |
| 02/25/2010 | US20100047282 method of accelerated vaccination against ebola viruses |
| 02/25/2010 | US20100047281 Variants of hepatitis b virus with resistance to anti-viral nucleoside agents and applications thereof |
| 02/25/2010 | US20100047280 Flavivirus ns1 subunit vaccine |
| 02/25/2010 | US20100047279 Immunological composition |
| 02/25/2010 | US20100047278 Human Rotavirus and Vaccine Composition Comprising Same |
| 02/25/2010 | US20100047277 Virosomes, methods of preparation, and immunogenic compositions |
| 02/25/2010 | US20100047276 Recombinant Vectors Based On the Modified Vaccinia Ankara Virus (MVA) as Preventive and Therapeutic Vaccines Against Aids |
| 02/25/2010 | US20100047275 Peptide sequences and compositions |
| 02/25/2010 | US20100047274 Inoculation of recombinant viral vectors for rapid pre-exposure prevention and post-exposure protection against alpha-virus-induced encephalitides |
| 02/25/2010 | US20100047273 Coxsackie B virus and type 1 diabetes |
| 02/25/2010 | US20100047272 Therapeutic vaccine comprising mycobacterial heat shock protein 70 |
| 02/25/2010 | US20100047271 Vaccine compositions |
| 02/25/2010 | US20100047268 Fusion proteins of hiv regulatory/accessory proteins |
| 02/25/2010 | US20100047267 Staphylococcus aureus proteins and nucleic acids |
| 02/25/2010 | US20100047266 Chimeric virus-like particles |
| 02/25/2010 | US20100047265 Active antiangiogenic therapy |
| 02/25/2010 | US20100047264 Immunogenic Affinity-Conjugated Antigen Systems Based on Papaya Mosaic Virus and Uses Thereof |
| 02/25/2010 | US20100047263 Peptides protective against s. pneumoniae and compositions, methods and uses relating thereto |
| 02/25/2010 | US20100047262 Novel method for down-regulation of amyloid |
| 02/25/2010 | US20100047261 Base-modified rna for increasing the expression of a protein |
| 02/25/2010 | US20100047260 Methods and Compositions Relating To a Vaccine Against Prostate Cancer |
| 02/25/2010 | US20100047259 Follistatin domain containing proteins |
| 02/25/2010 | US20100047258 Drug Carriers, Their Synthesis, and Methods of Use Thereof |
| 02/25/2010 | US20100047257 Antagonist antibody for the treatment of cancer |
| 02/25/2010 | US20100047256 Methods |
| 02/25/2010 | US20100047255 Novel activation and transfer cascade for ubiquitin |
| 02/25/2010 | US20100047254 High Affinity Human Antibodies to Human IL-4 Receptor |
| 02/25/2010 | US20100047253 Fully human monoclonal antibodies to il-13 |
| 02/25/2010 | US20100047252 Antibody with protein a selectivity |
| 02/25/2010 | US20100047251 Antibodies blocking fibroblast growth factor receptor activation and methods of use thereof |
| 02/25/2010 | US20100047250 Activation epitope of fcy rii (cd32), binding molecules that specifically bind the epitope and means and methods for the detection of the epitope, and uses of said epitope or said binding molecules |
| 02/25/2010 | US20100047249 INHIBITION OF FcyR-MEDIATED PHAGOCYTOSIS WITH REDUCED IMMUNOGLOBULIN PREPARATIONS |
| 02/25/2010 | US20100047248 Methods of processing compositions containing microparticles |
| 02/25/2010 | US20100047247 Nerve elongation promoter and elongation inhibitor |
| 02/25/2010 | US20100047246 Methods and Compositions for Treating Vascular Disease |
| 02/25/2010 | US20100047245 Complementary determining regions (CDR); interleukins (IL-12) |
| 02/25/2010 | US20100047244 Human CTLA-4 Antibodies and Their Uses |
| 02/25/2010 | US20100047243 Novel antibodies against igf-ir |
| 02/25/2010 | US20100047242 Pharmaceutical compositions capable of inducing apoptosis in tumour cells, useful for diagnosis and treatment of b-chronic lymphocytic leukaemia |
| 02/25/2010 | US20100047241 Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof |
| 02/25/2010 | US20100047240 Metastasis specific splice variants of mena and uses thereof in diagnosis, prognosis and treatment of tumors |
| 02/25/2010 | US20100047239 Dual variable domain immunoglobulin and uses thereof |
| 02/25/2010 | US20100047238 Humanized antibodies against |
| 02/25/2010 | US20100047237 Prevention of aggregation of immunoglobulin light or heavy chains |
| 02/25/2010 | US20100047236 Antibody variants |
| 02/25/2010 | US20100047235 Novel regimens for treating diseases and disorders |
| 02/25/2010 | US20100047234 Treating skin cancer |
| 02/25/2010 | US20100047233 Treatment of post-menopausal and post-hysterectomy mediated cognitive disorders |
| 02/25/2010 | US20100047232 Modulators of neuronal regeneration |